Business
TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development
Bruce Freedman, M.D. joins innovative MedTech company to advocate for more natural surgical hernia mesh options MALVERN, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE)
About this update from Tela Bio, Inc.
[{"type":"text","content":"Bruce Freedman, M.D. joins innovative MedTech company to advocate for more natural surgical hernia mesh options MALVERN, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (\"TELA\") (Nasdaq: TELA), an innovative MedTech company focused on advancing the field of soft-tissue reconstruction, announced today that it has welcomed Bruce Freedman, M.D., FACS as Vice President of Clinical Development. After 32 years as a private practice general surgeon specializing in hernia repair and abdominal wall reconstruction, Dr. Freedman has joined TELA Bio to advocate for a more natural hernia repair mesh option as an alternative to permanent and resorbable synthetic mesh. “As a surgeon who has performed thousands of hernia repairs with plastic mesh over the past three decades, I fully understand the clinical limitations of using synthetic mesh to repair human tissue,” said Dr. Freedman. “Unfortunately, plastic mesh has the potential to create a foreign body response and inflammation in some patients, the effects of which can cause complications immediately after surgery or even many years down the road. OviTex® is a very different material and was designed specifically to reduce this foreign-body response. As I incorporated it in my practice, I saw first-hand how the careful work that went into the design positively impacted my patients.” He added, “TELA Bio is providing much needed innovation in the hernia repair specialty, and I believe this product has remarkable potential to help surgeons break decades-long dependence on plastic mesh, while advancing treatment and better serving the patient.” In his role, Dr. Freedman will be using his extensive experience as a healthcare provider to share the clinical and financial benefits of the OviTex Reinforced Tissue Matrix portfolio with surgeons and hospital administration. “TELA Bio has spent the past several years working closely with surgeons in capturing and documenting clinical and financial evidence. They’ve got a powerful message, one I’m enthusiastic to help spread,” Dr. Freedman added. “We are thrilled to welcome Dr. Freedman to our team. Improving patient access to our innovative technology requires education throughout the healthcare delivery system, which includes surgeons, clinical resources, supply chain, hospital administrators, and patients,” said Antony Koblish, Co-founder, Pr...